Arbutus Biopharma Corp Premiums Earned, Net
Arbutus Biopharma Corp (ABUS) reported Premiums Earned, Net of $4.10 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PremiumsEarnedNet · last filed 2023-11-07
- Arbutus Biopharma Corp premiums earned, net for the quarter ending 2023-09-30 was $0.00.
- Arbutus Biopharma Corp premiums earned, net for the quarter ending 2023-06-30 was $0.00.
- Arbutus Biopharma Corp premiums earned, net for the quarter ending 2023-03-31 was $4.10M, a 0.00% change year-over-year.
- Arbutus Biopharma Corp premiums earned, net for the quarter ending 2022-09-30 was $0.00.
| Period end | Premiums Earned, Net 3 month | Premiums Earned, Net 6 month | Premiums Earned, Net 9 month |
|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $4.10M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.10M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $4.10M 10-Q · filed 2023-05-04 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $4.10M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.10M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $4.10M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |